Compare $DXR vs $RTGN | Chartloom

Compare

$DXR vs $RTGN

Daxor Corp · RetinalGenix Technologies Inc

DXR

Daxor Corp

RTGN

RetinalGenix Technologies Inc

Compare $DXR vs $RTGN

Comparing Daxor Corp and RetinalGenix Technologies Inc

DXRDaxor Corp

RTGNRetinalGenix Technologies Inc

DXRDaxor Corp

Market cap

$61M

P/E (TTM)

10.55x

Forward P/E (NTM)

—

Forward P/S (NTM)

4.27x

Rev growth (TTM)

-52.9%

YTD performance

-27.5%

52W performance

-11.3%

FCF yield

-13.5%

RTGNRetinalGenix Technologies Inc

Market cap

$75M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-100.0%

52W performance

-100.0%

FCF yield

-0.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DXR

RTGN

Detailed metrics comparison

DXR

Daxor Corp

RTGN

RetinalGenix Technologies Inc

Market Cap

DXR$61M

RTGN$75M

Enterprise Value

DXR$61M

RTGN$75M

Price

DXR$10.41

RTGN$0.00

P/E Ratio

DXR10.55x

RTGNN/A

P/S Ratio

DXR1,942.31x

RTGN0.00x

EV/Sales

DXR1,942.31x

RTGN0.00x

EV/EBITDA

DXR6,283.06x

RTGN0.00x

P/B Ratio

DXR1.21x

RTGNN/A

P/FCF Ratio

DXRN/A

RTGNN/A

EV/FCF

DXR-7.43x

RTGN-157.37x

PEG Ratio

DXRN/A

RTGNN/A

Forward P/E (NTM)

DXRN/A

RTGNN/A

Forward P/S (NTM)

DXR4.27x

RTGNN/A

Revenue (TTM)

DXR$31K

RTGN$0

Revenue Growth (YoY)

DXR-52.9%

RTGNN/A

Forward Rev Growth

DXR76.3%

RTGN0.0%

Gross Margin (TTM)

DXR-5782.1%

RTGN0.0%

Operating Margin (TTM)

DXR0.0%

RTGN0.0%

EBITDA Margin (TTM)

DXR-6055.0%

RTGN0.0%

Net Margin (TTM)

DXR19899.7%

RTGN0.0%

FCF Margin (TTM)

DXR-26130.7%

RTGNN/A

Net Income (TTM)

DXR$6M

RTGN$-2M

FCF (TTM)

DXR$-8M

RTGN$-478K

EPS (TTM)

DXR$0.99

RTGN-$0.11

ROE (TTM)

DXR12.8%

RTGN-37602230.0%

ROA (TTM)

DXR12.7%

RTGN-1265210.0%

ROIC (TTM)

DXR12.8%

RTGN0.0%

Cash

DXR$0

RTGN$27K

Debt

DXR$0

RTGN$49K

Net Cash/Debt

DXR$0

RTGN$-22K

Current Ratio (TTM)

DXR2.88x

RTGN0.01x

Quick Ratio (TTM)

DXR2.88x

RTGN0.01x

Debt/Equity (TTM)

DXR0.00x

RTGN0.00x

Debt/Assets (TTM)

DXR0.0%

RTGN0.0%

Interest Coverage (TTM)

DXRN/A

RTGNN/A

Net Debt/EBITDA (TTM)

DXR0.00x

RTGN0.00x

Beta

DXR0.38

RTGN2.32

52W Performance

DXR-11.3%

RTGN-100.0%

YTD Performance

DXR-27.5%

RTGN-100.0%

% from 52W High

DXR-29.5%

RTGN-100.0%

% from 52W Low

DXR21.6%

RTGNN/A

Asset Turnover (TTM)

DXR0.00x

RTGN0.00x

FCF Yield (TTM)

DXR-13.5%

RTGN-0.6%

Earnings Yield (TTM)

DXR10.2%

RTGN-2.8%

Dividend Yield (TTM)

DXRN/A

RTGNN/A

Rule of 40

DXR-26,183.5

RTGN0.0

EV/GP/RG

DXRN/A

RTGNN/A

Ticker research

View DXR research View RTGN research

Metric	DXR Daxor Corp	RTGN RetinalGenix Technologies Inc
Market & Valuation
Market Cap	$61M	$75M
Enterprise Value	$61M	$75M
Price	$10.41	$0.00
P/E Ratio	10.55x	N/A
P/S Ratio	1,942.31x	0.00x
EV/Sales	1,942.31x	0.00x
EV/EBITDA	6,283.06x	0.00x
P/B Ratio	1.21x	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	-7.43x	-157.37x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.27x	N/A
Revenue & Growth
Revenue (TTM)	$31K	$0
Revenue Growth (YoY)	-52.9%	N/A
Forward Rev Growth	76.3%	0.0%
Profitability
Gross Margin (TTM)	-5782.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-6055.0%	0.0%
Net Margin (TTM)	19899.7%	0.0%
FCF Margin (TTM)	-26130.7%	N/A
Net Income (TTM)	$6M	$-2M
FCF (TTM)	$-8M	$-478K
EPS (TTM)	$0.99	-$0.11
ROE (TTM)	12.8%	-37602230.0%
ROA (TTM)	12.7%	-1265210.0%
ROIC (TTM)	12.8%	0.0%
Financial Health
Cash	$0	$27K
Debt	$0	$49K
Net Cash/Debt	$0	$-22K
Current Ratio (TTM)	2.88x	0.01x
Quick Ratio (TTM)	2.88x	0.01x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.38	2.32
52W Performance	-11.3%	-100.0%
YTD Performance	-27.5%	-100.0%
% from 52W High	-29.5%	-100.0%
% from 52W Low	21.6%	N/A
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-13.5%	-0.6%
Earnings Yield (TTM)	10.2%	-2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-26,183.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DXR research	View RTGN research

Valuation

P/E Ratio

DXR

10.55x

P/S Ratio

RTGN

0.00x

DXR

1,942.31x

EV/FCF

RTGN

-157.37x

DXR

-7.43x

Growth & revenue

Revenue Growth TTM

DXR

-52.9%

Forward Revenue Growth

DXR

76.3%

RTGN

0.0%

Profitability & performance

Gross Margin

RTGN

0.0%

DXR

-5782.1%

ROE

DXR

12.8%

RTGN

-37602230.0%

FCF Yield %

RTGN

-0.6%

DXR

-13.5%

52-Week Performance

DXR

-11.3%

RTGN

-100.0%

Detailed metrics comparison

DXR

Daxor Corp

RTGN

RetinalGenix Technologies Inc

Market Cap

DXR$61M

RTGN$75M

Enterprise Value

DXR$61M

RTGN$75M

Price

DXR$10.41

RTGN$0.00

P/E Ratio

DXR10.55x

RTGNN/A

P/S Ratio

DXR1,942.31x

RTGN0.00x

EV/Sales

DXR1,942.31x

RTGN0.00x

EV/EBITDA

DXR6,283.06x

RTGN0.00x

P/B Ratio

DXR1.21x

RTGNN/A

P/FCF Ratio

DXRN/A

RTGNN/A

EV/FCF

DXR-7.43x

RTGN-157.37x

PEG Ratio

DXRN/A

RTGNN/A

Forward P/E (NTM)

DXRN/A

RTGNN/A

Forward P/S (NTM)

DXR4.27x

RTGNN/A

Revenue (TTM)

DXR$31K

RTGN$0

Revenue Growth (YoY)

DXR-52.9%

RTGNN/A

Forward Rev Growth

DXR76.3%

RTGN0.0%

Gross Margin (TTM)

DXR-5782.1%

RTGN0.0%

Operating Margin (TTM)

DXR0.0%

RTGN0.0%

EBITDA Margin (TTM)

DXR-6055.0%

RTGN0.0%

Net Margin (TTM)

DXR19899.7%

RTGN0.0%

FCF Margin (TTM)

DXR-26130.7%

RTGNN/A

Net Income (TTM)

DXR$6M

RTGN$-2M

FCF (TTM)

DXR$-8M

RTGN$-478K

EPS (TTM)

DXR$0.99

RTGN-$0.11

ROE (TTM)

DXR12.8%

RTGN-37602230.0%

ROA (TTM)

DXR12.7%

RTGN-1265210.0%

ROIC (TTM)

DXR12.8%

RTGN0.0%

Cash

DXR$0

RTGN$27K

Debt

DXR$0

RTGN$49K

Net Cash/Debt

DXR$0

RTGN$-22K

Current Ratio (TTM)

DXR2.88x

RTGN0.01x

Quick Ratio (TTM)

DXR2.88x

RTGN0.01x

Debt/Equity (TTM)

DXR0.00x

RTGN0.00x

Debt/Assets (TTM)

DXR0.0%

RTGN0.0%

Interest Coverage (TTM)

DXRN/A

RTGNN/A

Net Debt/EBITDA (TTM)

DXR0.00x

RTGN0.00x

Beta

DXR0.38

RTGN2.32

52W Performance

DXR-11.3%

RTGN-100.0%

YTD Performance

DXR-27.5%

RTGN-100.0%

% from 52W High

DXR-29.5%

RTGN-100.0%

% from 52W Low

DXR21.6%

RTGNN/A

Asset Turnover (TTM)

DXR0.00x

RTGN0.00x

FCF Yield (TTM)

DXR-13.5%

RTGN-0.6%

Earnings Yield (TTM)

DXR10.2%

RTGN-2.8%

Dividend Yield (TTM)

DXRN/A

RTGNN/A

Rule of 40

DXR-26,183.5

RTGN0.0

EV/GP/RG

DXRN/A

RTGNN/A

Ticker research

View DXR research View RTGN research

Metric	DXR Daxor Corp	RTGN RetinalGenix Technologies Inc
Market & Valuation
Market Cap	$61M	$75M
Enterprise Value	$61M	$75M
Price	$10.41	$0.00
P/E Ratio	10.55x	N/A
P/S Ratio	1,942.31x	0.00x
EV/Sales	1,942.31x	0.00x
EV/EBITDA	6,283.06x	0.00x
P/B Ratio	1.21x	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	-7.43x	-157.37x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.27x	N/A
Revenue & Growth
Revenue (TTM)	$31K	$0
Revenue Growth (YoY)	-52.9%	N/A
Forward Rev Growth	76.3%	0.0%
Profitability
Gross Margin (TTM)	-5782.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-6055.0%	0.0%
Net Margin (TTM)	19899.7%	0.0%
FCF Margin (TTM)	-26130.7%	N/A
Net Income (TTM)	$6M	$-2M
FCF (TTM)	$-8M	$-478K
EPS (TTM)	$0.99	-$0.11
ROE (TTM)	12.8%	-37602230.0%
ROA (TTM)	12.7%	-1265210.0%
ROIC (TTM)	12.8%	0.0%
Financial Health
Cash	$0	$27K
Debt	$0	$49K
Net Cash/Debt	$0	$-22K
Current Ratio (TTM)	2.88x	0.01x
Quick Ratio (TTM)	2.88x	0.01x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.38	2.32
52W Performance	-11.3%	-100.0%
YTD Performance	-27.5%	-100.0%
% from 52W High	-29.5%	-100.0%
% from 52W Low	21.6%	N/A
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-13.5%	-0.6%
Earnings Yield (TTM)	10.2%	-2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-26,183.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DXR research	View RTGN research